Lexeo Therapeutics Ownership | Who Owns Lexeo Therapeutics?


OverviewForecastFinancialsChart

Lexeo Therapeutics Ownership Summary


Lexeo Therapeutics is owned by 84.58% institutional investors, 0.75% insiders, and 14.67% retail investors. Opaleye management is the largest institutional shareholder, holding 0% of LXEO shares.

LXEO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLexeo Therapeutics84.58%0.75%14.67%
SectorHealthcare Stocks 278.45%10.60%-189.04%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Opaleye management---
Metlife investment management---
Nelson, van denburg & campbell wealth management group---
Rothschild investment---
Jane street group---
Gamma investing---
Altium capital management lp---
Aristides capital---
Walleye capital---
Wellington management group llp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management---
Metlife investment management---
Nelson, van denburg & campbell wealth management group---
Rothschild investment---
Jane street group---
Gamma investing---
Altium capital management lp---
Aristides capital---
Walleye capital---
Wellington management group llp---

Top Buyers

HolderShares% AssetsChange
Rothschild investment---20.00
Nelson, van denburg & campbell wealth management group---185.00
Gamma investing---245.00
Russell investments group---416.00
Skopos labs---1.47K

Top Sellers

HolderShares% AssetsChange
Eventide asset management---1.23M
Altium capital management lp---405.00K
Opaleye management---130.00K
Wellington management group llp---76.98K
Walleye capital---61.93K

Sold Out

HolderChange
Rothschild investment-20.00
Nelson, van denburg & campbell wealth management group-185.00
Gamma investing-245.00
Russell investments group-416.00
Skopos labs-1.47K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025914.60%28,007,979-3.59%841.10%42-26.32%23109.09%
Dec 31, 20248932.84%29,519,159-0.73%891.10%5913.46%1137.50%
Sep 30, 20246717.54%29,735,11411.93%891.39%5233.33%8-38.46%
Jun 30, 2024575.56%26,566,62614.91%801.18%39-15.22%13160.00%
Mar 31, 20245474.19%23,119,89342.94%822.24%4648.39%5-

Recent Insider Transactions


DateNameRoleActivityValue
May 16, 2025Townsend Richard Nolan Chief Executive OfficerSell$2.98K
May 16, 2025Adler Eric Chief Medical OfficerSell$1.62K
May 16, 2025Robertson Jenny Chief Legal OfficerSell$1.45K
May 16, 2025See Tai Sandi Chief Development OfficerSell$1.02K
Feb 19, 2025Townsend Richard Nolan Chief Executive OfficerSell$19.09K

Insider Transactions Trends


DateBuySell
2025 Q1-4
2024 Q413
2024 Q3-1
2023 Q42-

LXEO Ownership FAQ


Who Owns Lexeo Therapeutics?

Lexeo Therapeutics shareholders are primarily institutional investors at 84.58%, followed by 0.75% insiders and 14.67% retail investors. The average institutional ownership in Lexeo Therapeutics's industry, Biotech Stocks , is 63.84%, which Lexeo Therapeutics exceeds.

Who owns the most shares of Lexeo Therapeutics?

Lexeo Therapeutics’s largest shareholders are Opaleye management (0 shares, 0%), Metlife investment management (0 shares, 0%), and Nelson, van denburg & campbell wealth management group (0 shares, 0%). Together, they hold 0% of Lexeo Therapeutics’s total shares outstanding.

Does Blackrock own Lexeo Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Lexeo Therapeutics.

Who is Lexeo Therapeutics’s biggest shareholder by percentage of total assets invested?

Opaleye management is Lexeo Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Lexeo Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools